SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-21-003811
Filing Date
2021-02-16
Accepted
2021-02-16 07:57:57
Documents
52
Period of Report
2020-12-31

Document Format Files

Seq Description Document Type Size
1 form10-q.htm 10-Q 372397
2 ex31-1.htm EX-31.1 17581
3 ex31-2.htm EX-31.2 17449
4 ex32-1.htm EX-32.1 10216
5 ex32-2.htm EX-32.2 10102
  Complete submission text file 0001493152-21-003811.txt   2126947

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE FILE sonn-20201231.xml EX-101.INS 206232
7 XBRL SCHEMA FILE sonn-20201231.xsd EX-101.SCH 75419
8 XBRL CALCULATION FILE sonn-20201231_cal.xml EX-101.CAL 39373
9 XBRL DEFINITION FILE sonn-20201231_def.xml EX-101.DEF 90473
10 XBRL LABEL FILE sonn-20201231_lab.xml EX-101.LAB 323949
11 XBRL PRESENTATION FILE sonn-20201231_pre.xml EX-101.PRE 151170
Mailing Address 100 OVERLOOK CENTER SUITE 102 PRINCETON NJ 08540
Business Address 100 OVERLOOK CENTER SUITE 102 PRINCETON NJ 08540 609-375-2227
Sonnet BioTherapeutics Holdings, Inc. (Filer) CIK: 0001106838 (see all company filings)

IRS No.: 522102141 | State of Incorp.: DE | Fiscal Year End: 0930
Type: 10-Q | Act: 34 | File No.: 001-35570 | Film No.: 21632610
SIC: 2834 Pharmaceutical Preparations